Patent 7534775 was granted and assigned to Sangamo Biosciences Inc. on May, 2009 by the United States Patent and Trademark Office.
Methods and compositions are provided for modulating cardiac contractility by regulating transcription of the phsopholamban gene using engineered zinc finger proteins.